Literature DB >> 8818973

Infection with GB virus C (GBV-C) in patients with chronic liver disease or on maintenance hemodialysis in Indonesia.

F Tsuda1, S Hadiwandowo, N Sawada, M Fukuda, T Tanaka, H Okamoto, Y Miyakawa, M Mayumi.   

Abstract

RNA of a non-A to E hepatitis virus identified recently and designated provisionally GB virus C(GBV-C), was sought in patients in Indonesia by reverse-transcription polymerase chain reaction with nested primers deduced from a helicase-like region. GBV-C RNA was detected in 32 (55%) of 58 patients on maintenance hemodialysis at a frequency significantly higher (P < 0.001) than that in seven (5%) of 149 patients with chronic liver disease. Co-infection with hepatitis C virus was observed in 26 (81%) of the 32 patients on hemodialysis and in five (71%) of the seven patients with liver disease who were infected with GBV-C. Complete identity was observed in a sequence of 100 base pairs in the helicase-like region for GBV-C cDNA clones from some patients on maintenance hemodialysis. These results indicate that the patients on hemodialysis would be at high risk for GBV-C infection, which would be transmitted by transfusion and patient-to-patient routes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818973     DOI: 10.1002/(SICI)1096-9071(199607)49:3<248::AID-JMV15>3.0.CO;2-8

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  A high frequency of GBV-C/HGV coinfection in hepatitis C patients in Germany.

Authors:  Jie Yan; Reinhard H Dennin
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Prevalence of GB virus C/Hepatitis G virus infection among various populations in Surabaya, Indonesia, and identification of novel groups of sequence variants.

Authors:  R Handajani; M I Lusida; P Suryohudoyo; P Adi; P B Setiawan; C A Nidom; R Soemarto; Y Katayama; M Fujii; H Hotta
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Hepatitis G virus infection in Amerindians and other Venezuelan high-risk groups.

Authors:  F H Pujol; Y E Khudyakov; M Devesa; M E Cong; C L Loureiro; L Blitz; F Capriles; S Beker; F Liprandi; H A Fields
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  GB virus C in patients with liver disease of unknown etiology.

Authors:  E Quirós; G Piédrola; C Maroto
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 5.  GB virus C/hepatitis G virus (GBV-C/HGV): still looking for a disease.

Authors:  M Sathar; P Soni; D York
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

6.  Clinical course of chronic hepatitis C virus infection is not influenced by concurrent hepatitis G virus infection.

Authors:  J Hayashi; K Ueno; Y Kawakami; Y Kishihara; I Ariyama; N Furusyo; Y Sawayama; Y Etoh; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

7.  Detection of hepatitis G virus (HGV) RNA and antibodies to the HGV envelope protein E2 in a cohort of hemodialysis patients.

Authors:  T Pérez-Gracia; F Galán; J A Girón-González; A Lozano; B Benavides; E Fernández; M Rodríguez-Iglesias
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

8.  Hepatitis G virus infection in Egyptian children with chronic renal failure (single centre study).

Authors:  Ayman Mohammad Hammad; Mohammad Hosam El Deen Zaghloul
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-12-16       Impact factor: 3.944

9.  Hepatitis G virus exposure in dialysis patients.

Authors:  Ali Eslamifar; Rasool Hamkar; Amitis Ramezani; Farrokhlagha Ahmadi; Latif Gachkar; Somayeh Jalilvand; Ladan Adibi; Shahnaz Atabak; Ali Khameneh; Ramin Ghadimi; Arezoo Aghakhani
Journal:  Int Urol Nephrol       Date:  2007-09-05       Impact factor: 2.370

10.  Hepatitis G virus in the general population and in patients on hemodialysis.

Authors:  J Hayashi; N Furusyo; Y Sawayama; Y Kishihara; Y Kawakami; I Ariyama; Y Etoh; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.